Total (n=533) Composite Poor Outcome Composite Poor Outcome
OR
P-value
Adjusted OR
P-value
Yes (n=70)
No (n=463)
Gender; n (%) Gender; n (%) Gender; n (%) Gender; n (%)
Male 279 (52.3) 46 (65.7) 233 (50.3) 1.89 (1.12-3.20) 0.018 1.58 (0.82-3.06) 0.170
Female 254 (47.7) 24 (34.3) 230 (49.7) 1 1
Age; n (%)
Age <60 years 478 (89.7) 51 (72.9) 427 (92.2) 1 1
Age ≥60 years 55 (10.3) 19 (27.1) 36 (7.8) 4.42 (2.36-8.27) <0.001 1.93 (0.86-4.33) 0.111
Underlying risk condition; n (%) Underlying risk condition; n (%) Underlying risk condition; n (%) Underlying risk condition; n (%)
Yes 120 (22.5) 34 (48.6) 86 (18.6) 4.14 (2.45-6.99) <0.001 1.95 (1.01-3.73) 0.045
No 413 (77.5) 36 (51.4) 277 (81.4) 1 1
Obesity; n (%)
Yes 40 (7.5) 11 (15.7) 29 (6.3) 2.79 (1.32-5.88) 0.007 - -
No 493 (92.5) 59 (84.3) 434 (93.7) 1 -
Presented with pneumonia; n (%) Presented with pneumonia; n (%) Presented with pneumonia; n (%) Presented with pneumonia; n (%)
Yes 159 (29.8) 54 (77.1) 105 (22.7) 11.51 (6.32-20.94) <0.001 1.90 (0.88-4.11) 0.103
No 374 (70.2) 16 (22.9) 358 (77.3) 1 1
Time from onset of symptoms to hospital admission; n (%) Time from onset of symptoms to hospital admission; n (%) Time from onset of symptoms to hospital admission; n (%) Time from onset of symptoms to hospital admission; n (%)
Within 4 days 284/531 (53.5) 20/70 (28.6) 264/461 (57.3) 0.30 (0.17-0.52) <0.001 0.44 (0.23-0.84) 0.014
>4 days 247/531 (46.5) 50/70 (71.4) 197/461 (42.7) 1 1
Initial antiviral regimen; n (%) Initial antiviral regimen; n (%) Initial antiviral regimen; n (%) Initial antiviral regimen; n (%)
With FPV 138/384 (35.9) 54 (79.4) 84 (26.6) 10.65 (5.62-20.17) <0.001 5.31 (2.44-11.56) <0.001
Non-FPV 246/384 (64.1) 14 (20.6) 232 (73.4) 1 1
Received Azithromycin; n (%) Received Azithromycin; n (%) Received Azithromycin; n (%) Received Azithromycin; n (%)
Yes 129 (24.2) 37 (52.9) 92 (19.9) 4.52 (2.68-7.62) <0.001 2.22 (1.17-4.21) 0.014
No 404 (75.8) 33 (47.1) 371 (80.1) 1 1